long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
Published 2 years ago • 80 plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
3:18
zuma-5: axi-cel for r/r inhl
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
3:46
zuma-5 update: retreatment of r/r inhl with axi-cel
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
2:57
amogh smart 532nm | integrated laser slit lamp with advanced optics | appasamy associates
-
1:09:47
siduo 2022 - innovating in ultrasound:a 360-degree reviewfrom annular technology to ubm
-
26:31
survival analysis overview
-
1:08
zuma-7: overall survival benefit of axi-cel over soc in second-line lbcl
-
2:19
zuma-3: identifying the optimal dose of axi-cel in r/r all
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
0:54
zuma-3 end of phase i results: axi-cel for r/r all
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
1:15
primary overall survival analysis of the zuma-7 trial
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
3:23
final long-term follow-up results of the relaza2 study: mrd-guided treatment with aza in mds and aml
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
1:41
zuma-1: 3-year follow-up on axi-cel in lbcl patients
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
2:52
zuma-24 preliminary analysis of axi-cel in the outpatient setting in patients with r/r lbcl